Daily Research News Online

The global MR industry's daily paper since 2000

Conversation Intel Firm Unbounce Buys LeadsRx

January 14 2022

Canadian conversation intelligence platform Unbounce has acquired US marketing analytics platform LeadsRx for an undisclosed sum.

AJ BrownPortland, Oregon-based LeadsRx helps marketers understand the value of each customer touchpoint across digital, radio, TV, podcasts, streaming services and other advertising channels. The company's software and services - including multi-touch attribution, customer journey analytics and first-party data - are designed to help organizations improve customer acquisition efficiency, grow lifetime value, and identify wasted ad spend. Unlike other marketing attribution platforms, LeadsRx says it doesn't rely on third-party cookies but instead develops private identity graphs for each of its clients.

According to Unbounce, the acquisition will enable it to bring the power of marketing attribution to its small and midsize business customers. LeadsRx co-founder AJ Brown (pictured) will remain CEO while reporting to CEO of Unbounce, Felicia Bochicchio; and the 21-person LeadsRx team will continue to operate independently.

Tamara Grominsky, Chief Strategy Officer of Unbounce, comments: 'By combining LeadsRx's wealth of new data with our conversion intelligence platform, we have the opportunity to deliver conversion value to marketers across a wider spectrum of the marketing funnel. We're thrilled to welcome LeadsRx to the Unbounce team as we continue our journey of bringing conversion intelligence solutions to marketers around the world'.

Web sites: www.unbounce.com and www.leadsrx.com .

All articles 2006-22 written and edited by Mel Crowther and/or Nick Thomas unless otherwise stated.

Select a region below...
View all recent news
for UK
View all recent news
for USA
View all recent news
for Asia
View all recent news
for Australia


To receive (free) news headlines by email, please register online